The US Food and Drug Administration on Wednesday approved the second GLP-1 pill for weight loss, adding another option to a ...

Orforglipron is the second daily weight-loss pill to hit the market. The first was the Wegovy pill, from Novo Nordisk, which ...

India, April 2 -- The US Food and Drug Administration on Wednesday approved Foundayo, a new GLP-1 weight loss pill made by ...

The FDA has approved Foundayo (orforglipron) as a once‑daily GLP-1 pill to help adults lose excess weight and keep it off ...

Tirzepatide vs. semaglutide, which is better? Medical experts agree that tirzepatide has better results, but the right drug ...

(NewsNation) — Weight loss drugs have become an increasingly popular, but controversial, way of quickly shedding extra pounds over the past few years. Part of that controversy deals with the side ...

Federal regulators have approved the GLP-1 tablet Foundayo for weight loss. The once-daily oral pill provides an alternative ...

The Trump administration delayed Title X funding for reproductive care clinics that serve uninsured and low-income Americans.

Amazon Pharmacy began delivering GLP-1 medications in 2021, but does not stock injectable versions of the drugs in kiosks ...

Weight loss drugs and bariatric surgery may work differently, but they lead to surprisingly similar results inside the body.

A new study reports that replacing sugary beverages with artificially sweetened drinks can help promote weight loss, and that ...

Me Research Institute, a nonprofit medical research organization, announced the publication of a study that identifies ...